- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
MC3.2: 13 residues within 4Å:- Chain A: E.35, C.38, Y.245, S.246, F.248, L.249
- Chain C: F.14, G.15, S.18, L.21, L.22, L.279
- Ligands: MC3.29
Ligand excluded by PLIPMC3.3: 6 residues within 4Å:- Chain A: W.24, W.33, R.34, L.36, L.37
- Ligands: MC3.4
Ligand excluded by PLIPMC3.4: 9 residues within 4Å:- Chain A: L.21, L.22, L.23, W.24, R.25, Y.29, F.282
- Ligands: MC3.3, MC3.14
Ligand excluded by PLIPMC3.5: 4 residues within 4Å:- Chain A: Y.61, L.65
- Ligands: DU0.11, MC3.34
Ligand excluded by PLIPMC3.6: 2 residues within 4Å:- Chain A: F.42
- Ligands: DU0.11
Ligand excluded by PLIPMC3.7: 2 residues within 4Å:- Chain A: V.53
- Ligands: MC3.8
Ligand excluded by PLIPMC3.8: 4 residues within 4Å:- Chain A: M.44, F.52
- Ligands: MC3.7, MC3.10
Ligand excluded by PLIPMC3.9: 3 residues within 4Å:- Chain A: L.271, I.275
- Ligands: MC3.17
Ligand excluded by PLIPMC3.10: 2 residues within 4Å:- Chain A: C.272
- Ligands: MC3.8
Ligand excluded by PLIPMC3.12: 4 residues within 4Å:- Chain A: R.13, F.14
- Chain B: R.34, C.38
Ligand excluded by PLIPMC3.14: 13 residues within 4Å:- Chain A: F.14, G.15, S.18, L.21, L.22, L.279
- Chain B: E.35, C.38, Y.245, S.246, F.248, L.249
- Ligands: MC3.4
Ligand excluded by PLIPMC3.15: 6 residues within 4Å:- Chain B: W.24, W.33, R.34, L.36, L.37
- Ligands: MC3.16
Ligand excluded by PLIPMC3.16: 9 residues within 4Å:- Chain B: L.21, L.22, L.23, W.24, R.25, Y.29, F.282
- Ligands: MC3.15, MC3.38
Ligand excluded by PLIPMC3.17: 4 residues within 4Å:- Chain B: Y.61, L.65
- Ligands: MC3.9, DU0.23
Ligand excluded by PLIPMC3.18: 2 residues within 4Å:- Chain B: F.42
- Ligands: DU0.23
Ligand excluded by PLIPMC3.19: 2 residues within 4Å:- Chain B: V.53
- Ligands: MC3.20
Ligand excluded by PLIPMC3.20: 4 residues within 4Å:- Chain B: M.44, F.52
- Ligands: MC3.19, MC3.22
Ligand excluded by PLIPMC3.21: 3 residues within 4Å:- Chain B: L.271, I.275
- Ligands: MC3.41
Ligand excluded by PLIPMC3.22: 2 residues within 4Å:- Chain B: C.272
- Ligands: MC3.20
Ligand excluded by PLIPMC3.24: 4 residues within 4Å:- Chain B: R.13, F.14
- Chain D: R.34, C.38
Ligand excluded by PLIPMC3.25: 4 residues within 4Å:- Chain A: R.34, C.38
- Chain C: R.13, F.14
Ligand excluded by PLIPMC3.27: 13 residues within 4Å:- Chain C: E.35, C.38, Y.245, S.246, F.248, L.249
- Chain E: F.14, G.15, S.18, L.21, L.22, L.279
- Ligands: MC3.54
Ligand excluded by PLIPMC3.28: 6 residues within 4Å:- Chain C: W.24, W.33, R.34, L.36, L.37
- Ligands: MC3.29
Ligand excluded by PLIPMC3.29: 9 residues within 4Å:- Chain C: L.21, L.22, L.23, W.24, R.25, Y.29, F.282
- Ligands: MC3.2, MC3.28
Ligand excluded by PLIPMC3.30: 4 residues within 4Å:- Chain C: Y.61, L.65
- Ligands: DU0.36, MC3.59
Ligand excluded by PLIPMC3.31: 2 residues within 4Å:- Chain C: F.42
- Ligands: DU0.36
Ligand excluded by PLIPMC3.32: 2 residues within 4Å:- Chain C: V.53
- Ligands: MC3.33
Ligand excluded by PLIPMC3.33: 4 residues within 4Å:- Chain C: M.44, F.52
- Ligands: MC3.32, MC3.35
Ligand excluded by PLIPMC3.34: 3 residues within 4Å:- Chain C: L.271, I.275
- Ligands: MC3.5
Ligand excluded by PLIPMC3.35: 2 residues within 4Å:- Chain C: C.272
- Ligands: MC3.33
Ligand excluded by PLIPMC3.38: 13 residues within 4Å:- Chain B: F.14, G.15, S.18, L.21, L.22, L.279
- Chain D: E.35, C.38, Y.245, S.246, F.248, L.249
- Ligands: MC3.16
Ligand excluded by PLIPMC3.39: 6 residues within 4Å:- Chain D: W.24, W.33, R.34, L.36, L.37
- Ligands: MC3.40
Ligand excluded by PLIPMC3.40: 9 residues within 4Å:- Chain D: L.21, L.22, L.23, W.24, R.25, Y.29, F.282
- Ligands: MC3.39, MC3.52
Ligand excluded by PLIPMC3.41: 4 residues within 4Å:- Chain D: Y.61, L.65
- Ligands: MC3.21, DU0.47
Ligand excluded by PLIPMC3.42: 2 residues within 4Å:- Chain D: F.42
- Ligands: DU0.47
Ligand excluded by PLIPMC3.43: 2 residues within 4Å:- Chain D: V.53
- Ligands: MC3.44
Ligand excluded by PLIPMC3.44: 4 residues within 4Å:- Chain D: M.44, F.52
- Ligands: MC3.43, MC3.46
Ligand excluded by PLIPMC3.45: 3 residues within 4Å:- Chain D: L.271, I.275
- Ligands: MC3.55
Ligand excluded by PLIPMC3.46: 2 residues within 4Å:- Chain D: C.272
- Ligands: MC3.44
Ligand excluded by PLIPMC3.48: 4 residues within 4Å:- Chain D: R.13, F.14
- Chain E: R.34, C.38
Ligand excluded by PLIPMC3.50: 4 residues within 4Å:- Chain C: R.34, C.38
- Chain E: R.13, F.14
Ligand excluded by PLIPMC3.52: 13 residues within 4Å:- Chain D: F.14, G.15, S.18, L.21, L.22, L.279
- Chain E: E.35, C.38, Y.245, S.246, F.248, L.249
- Ligands: MC3.40
Ligand excluded by PLIPMC3.53: 6 residues within 4Å:- Chain E: W.24, W.33, R.34, L.36, L.37
- Ligands: MC3.54
Ligand excluded by PLIPMC3.54: 9 residues within 4Å:- Chain E: L.21, L.22, L.23, W.24, R.25, Y.29, F.282
- Ligands: MC3.27, MC3.53
Ligand excluded by PLIPMC3.55: 4 residues within 4Å:- Chain E: Y.61, L.65
- Ligands: MC3.45, DU0.61
Ligand excluded by PLIPMC3.56: 2 residues within 4Å:- Chain E: F.42
- Ligands: DU0.61
Ligand excluded by PLIPMC3.57: 2 residues within 4Å:- Chain E: V.53
- Ligands: MC3.58
Ligand excluded by PLIPMC3.58: 4 residues within 4Å:- Chain E: M.44, F.52
- Ligands: MC3.57, MC3.60
Ligand excluded by PLIPMC3.59: 3 residues within 4Å:- Chain E: L.271, I.275
- Ligands: MC3.30
Ligand excluded by PLIPMC3.60: 2 residues within 4Å:- Chain E: C.272
- Ligands: MC3.58
Ligand excluded by PLIP- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.11: 13 residues within 4Å:- Chain A: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.5, MC3.6
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.46, A:L.54, A:L.252
DU0.23: 13 residues within 4Å:- Chain B: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.17, MC3.18
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.46, B:L.54, B:L.252
DU0.36: 13 residues within 4Å:- Chain C: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.30, MC3.31
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.46, C:L.54, C:L.252
DU0.47: 13 residues within 4Å:- Chain D: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.41, MC3.42
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.46, D:L.54, D:L.252
DU0.61: 13 residues within 4Å:- Chain E: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.55, MC3.56
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:L.46, E:L.54, E:L.252
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
CD
AE
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
EC
CD
AE
B - Membrane
-
We predict this structure to be a membrane protein.